Details for Patent: 12,133,844
✉ Email this page to a colleague
Which drugs does patent 12,133,844 protect, and when does it expire?
Patent 12,133,844 protects FYARRO and is included in one NDA.
This patent has thirty-nine patent family members in twenty-six countries.
Summary for Patent: 12,133,844
| Title: | Methods of treating epithelioid cell tumors |
| Abstract: | The present invention provides methods and compositions for treating epithelioid cell tumors (such as a PEComa) by administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin. |
| Inventor(s): | Neil P. Desai |
| Assignee: | Abraxis Bioscience LLC |
| Application Number: | US17/165,652 |
|
Patent Claim Types: see list of patent claims |
More… ↓ |
Drugs Protected by US Patent 12,133,844
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 12,133,844 | ⤷ Subscribe | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) WITH A DOSE ADMINISTERED ON DAYS 1 AND 8 OF A 21-DAY CYCLE | ⤷ Subscribe | ||||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 12,133,844 | ⤷ Subscribe | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) WITH A DOSE OF 45 MG/M2 OR 56 MG/M2 ADMINISTERED ON DAYS 1 AND 8 OF A 21-DAY CYCLE | ⤷ Subscribe | ||||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 12,133,844 | ⤷ Subscribe | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PECOMA) WITH A DOSE OF 45 MG/M2 ADMINISTERED ON DAYS 1 AND 8 OF A 21-DAY CYCLE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,133,844
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016285720 | ⤷ Subscribe | |||
| Australia | 2021286245 | ⤷ Subscribe | |||
| Brazil | 112017027954 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
